Search research articles
Contact Us
Filters
Showing results (241-250 of 262) with videos related to
Page
of 27
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Communications Biology
|
July 9, 2025
Triggering AHR resolves TGF-β1 induced fibroblast activation and promotes AT1 cell regeneration in alveolar organoids
Andrew S Hagan, Scott Williams, Casey J N Mathison, et al.
Journal of Vascular Surgery
|
May 23, 2020
The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An effort to advance evidence evaluation for vascular devices
Greg Tsougranis, Jens Eldrup-Jorgensen, Daniel Bertges, et al.
Nature Communications
|
August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
A M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
BJU International
|
July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)
Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
Molecular Cell
|
June 10, 2020
Endogenous DNA 3' Blocks Are Vulnerabilities for BRCA1 and BRCA2 Deficiency and Are Reversed by the APE2 Nuclease
Alejandro Álvarez-Quilón, Jessica L Wojtaszek, Marie-Claude Mathieu, et al.
Transfusion
|
May 18, 2016
A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti
Emmanuel Cornillot, Amina Dassouli, Niseema Pachikara, et al.
Lancet (London, England)
|
March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
European Urology Oncology
|
November 29, 2024
Baseline Nodal Status on <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
Michael S Hofman, Veeru Kasivisvanathan, Emma Link, et al.
Page
of 27
Search research articles
Search
Showing results (241-250 of 262) with videos related to
Sort By:
Page
of 27
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
November 17, 2019
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of <sup>177</sup>Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet, Shahneen Sandhu, Amir Iravani, et al.
Communications Biology
|
July 9, 2025
Triggering AHR resolves TGF-β1 induced fibroblast activation and promotes AT1 cell regeneration in alveolar organoids
Andrew S Hagan, Scott Williams, Casey J N Mathison, et al.
Journal of Vascular Surgery
|
May 23, 2020
The Vascular Implant Surveillance and Interventional Outcomes (VISION) Coordinated Registry Network: An effort to advance evidence evaluation for vascular devices
Greg Tsougranis, Jens Eldrup-Jorgensen, Daniel Bertges, et al.
Nature Communications
|
August 10, 2023
Copy number architectures define treatment-mediated selection of lethal prostate cancer clones
A M Mahedi Hasan, Paolo Cremaschi, Daniel Wetterskog, et al.
BJU International
|
July 17, 2021
'Pain-free TRUS B': a phase 3 double-blind placebo-controlled randomized trial of methoxyflurane with periprostatic local anaesthesia to reduce the discomfort of transrectal ultrasonography-guided prostate biopsy (ANZUP 1501)
Dickon Hayne, Jeremy Grummet, David Espinoza, et al.
Molecular Cell
|
June 10, 2020
Endogenous DNA 3' Blocks Are Vulnerabilities for BRCA1 and BRCA2 Deficiency and Are Reversed by the APE2 Nuclease
Alejandro Álvarez-Quilón, Jessica L Wojtaszek, Marie-Claude Mathieu, et al.
Transfusion
|
May 18, 2016
A targeted immunomic approach identifies diagnostic antigens in the human pathogen Babesia microti
Emmanuel Cornillot, Amina Dassouli, Niseema Pachikara, et al.
Lancet (London, England)
|
March 27, 2020
Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study
Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
European Urology Oncology
|
November 29, 2024
Baseline Nodal Status on <sup>68</sup>Ga-PSMA-11 Positron Emission Tomography/Computed Tomography in Men with Intermediate- to High-risk Prostate Cancer Is Prognostic for Treatment Failure: Follow-up of the proPSMA Trial
Michael S Hofman, Veeru Kasivisvanathan, Emma Link, et al.
Page
of 27